| ASPsiDb_ID | Mutant allele/ASP-siRNA | Mutant efficacy (%) |
Wild efficacy (%) |
Percentage discrimination (%) |
Gene | Disease | Analysis | Pubmed ID |
|---|---|---|---|---|---|---|---|---|
| ASPsiDb_ID | Mutant allele/ASP-siRNA | Mutant efficacy (%) |
Wild efficacy (%) |
Percentage discrimination (%) |
Gene | Disease | Analysis | Pubmed ID |
| aspsirna0974 | GUCGUCGUCGUCGUCGUCGUC CAGCAGCAGCAGCAGCAGCAG |
68 | 15 | 53 | Ribosomal protein L14 (RPL14) | Neurological disorder | 
|
|
| aspsirna0975 | GUCGUCGUCGUCGUCGUCGUC CAGCAGCAGCAGCAGCAGCAG |
65 | 20 | 45 | Low density lipoprotein receptor-related protein 8 (LRP8) | Neurological disorder |
|
|
| aspsirna0976 | GUCGUCGUCGUCGUCGUCGUC CAGCAGCAGCAGCAGCAGCAG |
70 | 52 | 18 | EIF2AK (EIF2AK1) | Neurological disorder |
|
|
| aspsirna0978 | CAGCAGCAGCAGCAGCAGCAGCAGCAG GUCGUCGUCGUCGUCGUCGUCGUCGUC |
56 | 39 | 17 | Ataxin-1 (ATXN1) | Neurological disorder |
|
|
| aspsirna0980 | GUCGUCGUCGUCGUCGUCGUCGUCGUC CAGCAGCAGCAGCAGCAGCAGCAGCAG |
63 | 15 | 48 | Ribosomal protein L14 (RPL14) | Neurological disorder |
|
|
| aspsirna0981 | GUCGUCGUCGUCGUCGUCGUCGUCGUC CAGCAGCAGCAGCAGCAGCAGCAGCAG |
60 | 20 | 40 | Low density lipoprotein receptor-related protein 8 (LRP8) | Neurological disorder |
|
|
| aspsirna0982 | GUCGUCGUCGUCGUCGUCGUCGUCGUC CAGCAGCAGCAGCAGCAGCAGCAGCAG |
70 | 50 | 20 | EIF2AK (EIF2AK1) | Neurological disorder |
|